Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
12.65B | 12.63B | 12.49B | 12.21B | 12.37B | 11.79B | Gross Profit |
4.69B | 10.69B | 5.08B | 4.91B | 5.08B | 4.42B | EBIT |
605.00M | 542.00M | 957.00M | 821.00M | 1.40B | 1.13B | EBITDA |
1.09B | 1.07B | 1.54B | 1.74B | 1.93B | 2.02B | Net Income Common Stockholders |
-487.00M | -516.00M | -133.00M | 179.00M | 368.00M | 511.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
431.00M | 37.00M | 38.00M | 118.00M | 507.00M | 1.68B | Total Assets |
13.89B | 14.05B | 14.46B | 14.67B | 15.22B | 16.01B | Total Debt |
11.98B | 12.10B | 12.17B | 12.39B | 12.82B | 12.88B | Net Debt |
11.55B | 12.06B | 12.14B | 12.27B | 12.31B | 11.21B | Total Liabilities |
15.22B | 15.37B | 15.28B | 15.40B | 16.03B | 17.06B | Stockholders Equity |
-1.92B | -1.91B | -1.39B | -1.37B | -1.37B | -1.63B |
Cash Flow | Free Cash Flow | ||||
152.00M | 120.00M | -257.00M | -124.00M | -603.00M | 1.74B | Operating Cash Flow |
504.00M | 480.00M | 210.00M | 300.00M | -131.00M | 2.18B | Investing Cash Flow |
267.00M | -275.00M | -26.00M | -259.00M | -524.00M | 177.00M | Financing Cash Flow |
-388.00M | -206.00M | -264.00M | -430.00M | -514.00M | -895.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | $1.04B | 25.37 | 8.37% | ― | 3.71% | 1.32% | |
57 Neutral | $514.92M | ― | 39.18% | ― | 1.05% | -288.07% | |
53 Neutral | $795.17M | 18.62 | -21.08% | ― | -18.13% | -215.78% | |
53 Neutral | $5.14B | 3.23 | -45.01% | 2.85% | 17.55% | -0.69% | |
52 Neutral | $530.60M | ― | -12.03% | ― | 12.19% | -1.59% | |
49 Neutral | $517.51M | ― | -22.81% | ― | -1.08% | -65.84% | |
47 Neutral | $443.23M | ― | -4.00% | ― | -29.16% | -140.16% |
At the Annual Meeting on May 13, 2025, Community Health Systems, Inc. stockholders approved several key proposals, including the amendment and restatement of the 2009 Stock Option and Award Plan and a Certificate of Amendment for officer exculpation under Delaware law. The meeting also saw the election of directors, approval of executive compensation, and ratification of Deloitte & Touche LLP as the independent auditor for 2025, reflecting shareholder support for the company’s strategic and governance initiatives.
The most recent analyst rating on (CYH) stock is a Buy with a $6.00 price target. To see the full list of analyst forecasts on Community Health stock, see the CYH Stock Forecast page.
On May 9, 2025, Community Health Systems, Inc. completed the sale and issuance of $700 million in 10.750% Senior Secured Notes due 2033, using the proceeds to redeem its outstanding 8.000% Senior Secured Notes due 2027. The company also amended the indenture governing its 6.875% Senior Unsecured Notes due 2028, removing several restrictive covenants and provisions, which could impact its financial flexibility and operations.
On May 7, 2025, Community Health Systems, Inc. announced the early tender results of its cash tender offer for its 6.875% Senior Unsecured Notes due 2028. By the early tender deadline on May 6, 2025, approximately 93.32% of the outstanding notes were validly tendered and accepted for purchase, with payment expected on May 8, 2025. The company also received the necessary consent from note holders to adopt proposed amendments to the notes’ indenture, which will be enacted through a supplemental indenture on the early settlement date.
On April 23, 2025, Community Health Systems, Inc. reported its financial results for the first quarter ending March 31, 2025, showing net operating revenues of $3.159 billion and a reduced net loss of $13 million compared to the same period in 2024. The company experienced growth in same-store admissions and adjusted admissions, attributed to strong demand for services, and completed several divestitures to reduce debt. Despite challenges in the healthcare sector, the company remains optimistic about its strategic positioning for long-term success.